Tufts eClinical Study: Complexity Overrunning Technology

“We generally view the introduction of new technology solutions, particularly very expensive ones, as those that would contribute to a level of efficiency and speed,” suggests Dr. Ken Getz, Research Associate Professor at the Tufts Center for the Study of Drug Development. But, what does the Center’s recent 2017 eClinical Landscape Study reveal?  Listen to find out, and learn more about technology's growing and often surprising impact at DIA’s Regulatory Submissions, Information & Document Management Forum.